Examkin

Soru

Zorluk: OrtaSleep-Wake Disorders

An otherwise healthy 22-year-old college student seeks medical advice because of irrepressible daytime sleepiness that has been present for the last six months. She consistently falls asleep during her morning lectures and on the bus commute, despite maintaining a regular schedule of eight hours of sleep per night. She notes that her nighttime sleep is frequently fragmented. When asked about other symptoms, she describes several alarming episodes where her knees suddenly buckled and she experienced transient facial weakness specifically when laughing at a friend's joke, forcing her to sit down immediately. Additionally, she reports occasionally seeing a frightening, shadowy figure in her room just as she is drifting off to sleep. Her medical history is unremarkable, and she takes no medications or illicit substances. Vital signs and physical examination are within normal limits. Which of the following is most likely to be found during further evaluation of this patient?

  1. Decreased cerebrospinal fluid hypocretin-1 concentrationCevap
  2. B
    Decreased serum free thyroxine with an inappropriately normal thyroid-stimulating hormone
  3. C
    Functional decline with persistent auditory hallucinations lasting greater than 6 months
  4. D
    Manic symptoms recently provoked by the initiation of antidepressant monotherapy
  5. E
    Autonomic instability and hyperreflexia caused by an undetected pharmacological interaction

Cevap

The patient is most likely to have decreased levels of hypocretin-1 (orexin-A) in the cerebrospinal fluid.
The patient's clinical presentation of excessive daytime sleepiness, cataplexy (sudden, transient muscle weakness triggered by strong emotions like laughter), and hypnagogic hallucinations (visual hallucinations occurring at sleep onset) is highly characteristic of narcolepsy type 1. This primary sleep-wake disorder is fundamentally caused by the selective loss of orexin (hypocretin)-producing neurons situated in the lateral hypothalamus. Consequently, a diagnostic lumbar puncture in patients with narcolepsy type 1 classically reveals abnormally low levels of hypocretin-1 in the cerebrospinal fluid.

Adım Adım Çözüm

1
Analyze the core clinical symptoms.
The patient presents with excessive daytime sleepiness for 6 months, cataplexy (muscle weakness specifically with laughter), and hypnagogic hallucinations (seeing figures when falling asleep).
Identifying the cardinal symptoms and their exact triggers is the first step in diagnosing a primary sleep-wake disorder.
2
Synthesize the findings to formulate a diagnosis.
The combination of irrepressible daytime sleepiness, cataplexy, and hypnagogic hallucinations is pathognomonic for narcolepsy type 1.
Grouping the symptoms helps differentiate narcolepsy from other causes of hypersomnia, such as insufficient sleep syndrome or secondary fatigue.
3
Identify the underlying pathophysiology and expected diagnostic findings.
Narcolepsy type 1 is caused by the autoimmune destruction of hypocretin (orexin) neurons in the lateral hypothalamus, leading to definitively decreased hypocretin-1 levels in the cerebrospinal fluid.
The question asks for the most likely finding during further evaluation, requiring knowledge of the specific neurochemical marker for this disease.

Anahtar Kavram

Narcolepsy Type 1 pathophysiology and diagnosis
Bu soruyu puanla

Konular

Sleep-Wake Disorders

Bu konudan daha fazla soru